Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4724 total record number 96 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 1 out of 473
4724 citations found

Rapamycin alleviates mitochondrial dysfunction in anti-NMDAR encephalitis mice

Kong, L;Yang, X;Sun, A;Yang, X;Zhao, X;Wang, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A multi-omics systems vaccinology resource to develop and test computational models of immunity

Shinde, P;Soldevila, F;Reyna, J;Aoki, M;Rasmussen, M;Willemsen, L;Kojima, M;Ha, B;Greenbaum, JA;Overton, JA;Guzman-Orozco, H;Nili, S;Orfield, S;Gygi, JP;da Silva Antunes, R;Sette, A;Grant, B;Olsen, LR;Konstorum, A;Guan, L;Ay, F;Kleinstein, SH;Peters, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A Mucosal Vaccine Formulation Against Tuberculosis by Exploiting the Adjuvant Activity of S100a4A Damage-Associated Molecular Pattern Molecule

Abil, O;Liu, S;Yeh, Y;WU, Y;Sen Chaudhuri, A;Shan Li, N;Deng, C;Xiang, Z;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • 2.2. Immunization and collection of specimens

    Mice were anesthetized with isoflurane before receiving the vaccine preparation for intranasal immunization. A 20-µl phosphate-buffered saline (PBS) solution containing the Mtb antigen ESAT-6 (5 µg; MyBioSource; MBS204541) in the presence or absence of S100A4 (10 µg; Gentaur Molecular Products; 01-2081A4M; with His-tag) was administered dropwise to the external nares of the mice (10 µl per nostril). Some mice were immunized with ESAT-6 (5 µg) admixed to cholera toxin (CT; 1 μg; List Biological Labs; 100B) as a control adjuvant. Ten days after the last intranasal immunization, various tissues and samples were collected and analyzed, including blood, bronchoalveolar lavage fluid (BALF), nasal lavage, lungs, and spleen.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

A stress sensor, IRE1a, is required for bacterialexotoxin-induced interleukin-1b production in tissue-resident macrophages

Sasaki, I;Fukuda-Ohta, Y;Nakai, C;Wakaki-Nishiyama, N;Okamoto, C;Okuzaki, D;Morita, S;Kaji, S;Furuta, Y;Hemmi, H;Kato, T;Yamamoto, A;Tosuji, E;Saitoh, SI;Tanaka, T;Hoshino, K;Fukuda, S;Miyake, K;Kuroda, E;Ishii, KJ;Iwawaki, T;Furukawa, K;Kaisho, T;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Kurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition

Gu, C;Liu, Y;Lv, J;Zhang, C;Huang, Z;Jiang, Q;Gao, Y;Tao, T;Su, Y;Chen, B;Jia, R;Liu, X;Su, W;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Induction of EAU model

    On the initial day of the experiment, the mice were administered a subcutaneous injection containing a 1:1 combination of 200 μg of human interphotoreceptor retinoid-binding protein 1–20 (IRBP1–20, GPTHLFQPSLVLDMAKVLLD; GiL Biochem, Shanghai, China) and complete Freund’s adjuvant (Difco, Detroit, MI, USA). The complete Freund’s adjuvant consisted of 2.5 mg/mL of Mycobacterium tuberculosis (BD Difco, San Jose, CA, USA). On the same day of immunization and two days thereafter, an intraperitoneal injection of 0.25 μg pertussis toxin (PTX) diluted in phosphate-buffered saline (PBS) was administered. The PTX used in this study was obtained from List Biological Laboratories located in Campbell, California, USA.

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation

Huang, N;Winans, T;Wyman, B;Oaks, Z;Faludi, T;Choudhary, G;Lai, ZW;Lewis, J;Beckford, M;Duarte, M;Krakko, D;Patel, A;Park, J;Caza, T;Sadeghzadeh, M;Morel, L;Haas, M;Middleton, F;Banki, K;Perl, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • ong three subcutaneous sites on the flank (between the shoulder blades and over each hip). Additionally, on Days 0 and 2, the mice were injected intraperitoneally with 200?ng pertussis toxin (PTx) (List Biological Laboratories, Campbell, CA) in 200?µl PBS119. Clinical evaluation of EAE Individual animals were observed daily and clinical scores were assessed on a 0-5 scale as follows: decre ... ong three subcutaneous sites on the flank (between the shoulder blades and over each hip). Additionally, on Days 0 and 2, the mice were injected intraperitoneally with 200?ng pertussis toxin (PTx) (List Biological Laboratories, Campbell, CA) in 200?µl PBS119. Clinical evaluation of EAE Individual animals were observed daily and clinical scores were assessed on a 0-5 scale as follows: decre

A cerebro-cerebellar network for learning visuomotor associations

Sendhilnathan, N;Bostan, AC;Strick, PL;Goldberg, ME;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • s into either the cerebellar hemisphere (Crus IIp) or the PrePMd. We injected small amounts (0.2?µl) of a mixture of rabies virus (CVS-N2c 4.5 × 109 pfu/mL; provided by M. Schnell) and 0.02% CTb (List Biological Laboratories) at depths at least 0.5?mm apart along the injection tracks. Craniotomies and depths of injection tracks were based on structural magnetic resonance images previously ac ... s into either the cerebellar hemisphere (Crus IIp) or the PrePMd. We injected small amounts (0.2?µl) of a mixture of rabies virus (CVS-N2c 4.5 × 109 pfu/mL; provided by M. Schnell) and 0.02% CTb (List Biological Laboratories) at depths at least 0.5?mm apart along the injection tracks. Craniotomies and depths of injection tracks were based on structural magnetic resonance images previously ac

Alpha7 nicotinic acetylcholine receptor agonist PHA 568487 dampens inflammation in PBMCs from patients with newly discovered coronary artery disease

Mjörnstedt, F;Wilhelmsson, R;Ulleryd, M;Hammarlund, M;Bergström, G;Gummesson, A;Johansson, M;

Product: Unspecified List Labs LPS

  • ulations, PBMCs were seeded at a concentration of 2×105 cells/well in triplicates and stimulated with LPS (8.33 ng/ml, List Biological Laboratories Inc., Campbell, USA) with/without ?7nAChR agonist PHA568487 (83 ?M) for 4 hours as previously described2. Supernatants were analyzed using the Bio-Plex Pro Human Cytokine Panel 17-plex assay (Bio Rad Laboratories, Inc. Hercules, USA) following the manufacturer’s protocol. Inclusion criteria for each participant: Following LPS stimulation, TNF response 200 pg/ml and 10 times higher compared to unstimulated controls receiving PBS. PBMC viability after sti

Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay

Portillo, S;Oshinsky, J;Williams, M;Yoder, S;Liang, Y;Campbell, JD;Laufer, MK;Neuzil, KM;Edwards, KM;Pasetti, MF;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • ere obtained from List Biological Laboratories (Campbell, CA). FHA was obtained from Enzo Life Sciences (Farmingdale, NY). DT and TT were obtained from Statens Serum Institut (Copenhagen, Denmark) and from the N

Product: Tetanus Toxoid from Clostridium tetani

  • red µL of CGM alone (negative control), Phytohemagglutinin-A/L (PHA-L) in CGM at 5 µg/mL (positive control), MARV peptides (Appendix A Table A4) at 10-20 g/mL, tetanus toxoid (positive control) (List laboratories, Campbell, CA, USA) at 2 g/mL, or tetanus peptide (positive control) (TT830-844) at 10 g/mL were added. Peptides used for macaque microsphere immunization were added to the wells a